Literature DB >> 6171495

alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma.

S Govindarajan, M Ashcavai, R L Peters.   

Abstract

alpha-1-Antitrypsin deficiency due to homozygous Pi ZZ state is reported to be associated with cirrhosis and hepatocellular carcinoma (HCC); however, the role of heterozygous Pi Z state is not definitely known. In order to investigate the possible association, we studied the phenotypic distribution of alpha-1-antitrypsin variants (Pi) in 124 cases of HCC. Two thousand ten normal American Red Cross blood donors were studied as controls. Twelve patients with HCC had aberrant phenotypes, an incidence of 9.67% as compared to 8.36% among normal controls. Nine of 12 patients with HCC with aberrant Pi type had cirrhosis; 5 of the 9 had cirrhosis due to hepatitis B virus; 2 of the 9 had alcoholic liver disease with cirrhosis, and 2 had cryptogenic cirrhosis. The three patients with HCC arising in noncirrhotic livers who also had aberrant Pi phenotypes, had a relatively rare variety of HCC called fibrolamellar type. Z gene was found in five patients: all five were MZ. Incidence of MZ phenotype in HCC was similar to that of the normal control population (4.0% in HCC and 2.9% in the controls). However, 3 of 5 MZ were associated with fibrolamellar HCC. Another aberrant phenotype found among the patients with HCC was MF (fast moving) which occurred with an incidence of 2.41% as compared to none in the control group. In conclusion, we found no significant increase in the incidence of Z gene among 124 patients with HCC as compared to the normal population.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171495     DOI: 10.1002/hep.1840010611

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  A young woman with liver cancer.

Authors:  Celina S Ang; Richard K Do; Ali Shamseddine; Eileen M O'Reilly; Ali Haydar; Ashwaq Al-Olayan; Walid Faraj; Fouad Boulos; Mohamed Naghy; Dorothy Makanjoula; Hassan Farran; Hassan Sibai; David Wehbe; David P Kelsen; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2013-01

2.  Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor.

Authors:  D H Teitelbaum; S Tuttle; L C Carey; K P Clausen
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

3.  [Alpha 1-antitrypsin deficiency: a review with special reference to the significance of heterozygous deficiency].

Authors:  M Schneider; G Pott; U Gerlach
Journal:  Klin Wochenschr       Date:  1986-03-03

4.  Fibrolamellar hepatocarcinoma: clinical, radiologic, and pathologic features.

Authors:  I R Francis; F P Agha; N W Thompson; D F Keren
Journal:  Gastrointest Radiol       Date:  1986

5.  An association between alpha 1-antitrypsin phenotype and chronic liver disease.

Authors:  Y Kishimoto; S Yamada; C Hirayama
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

Review 6.  Alpha-1-antitrypsin deficiency: current concepts.

Authors:  Alan T Mulgrew; Clifford C Taggart; N Gerry McElvaney
Journal:  Lung       Date:  2007-06-12       Impact factor: 2.584

Review 7.  Alpha 1-antitrypsin deficiency and liver disease.

Authors:  P Birrer; N G McElvaney; L M Chang-Stroman; R G Crystal
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

8.  Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma.

Authors:  Aleksandra Topic; Mila Ljujic; Dragica Radojkovic
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

9.  Alpha 1-antitrypsin and survival in hepatocellular carcinoma.

Authors:  A Tzonou; L Sparos; V Kalapothaki; X Zavitsanos; A Rebelakos; D Trichopoulos
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.